You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, IL, Dec. 3, 2015 — Astellas Pharma recently announced that Christeen Moburg has been named director, Stakeholder Engagement, within the Corporate Affairs Team. Moburg will be responsible for developing and implementing strategic stakeholder engagement initiatives to advance Astellas’ public policy, as well as business and reputational goals, in the U.S. and in support of the Americas. She will report to Margaret Long, vice president, Business Communications and Stakeholder Engagement.
“Through our relationships with key advocacy organizations, Astellas reinforces its commitment to patients and the stakeholders who are helping improve health of patients,” said Long. “Christeen’s extensive experience working with disease, patient and physician organizations ensures that Astellas will continue building and maintaining these important connections.”
Moburg brings more than 18 years of health care experience to Astellas. Most recently, she was alliance and advocacy director, US Corporate Affairs Oncology and Infectious Disease, at MedImmune (Astrazeneca), where she was responsible for developing enterprise strategy, building and enhancing partnerships with multiple advocacy groups and working collaboratively with internal stakeholders, including government affairs, marketing, compliance, brand teams, medical affairs, communications and other areas.
Moburg earned her bachelor’s in business and marketing from American Intercontinental University.
The Corporate Affairs Department at Astellas combines Corporate, Employee and Business Communications; Government Affairs and Public Policy; Astellas US Foundation; Stakeholder Engagement; Corporate Branding; Corporate Social Responsibility; Medical and Development Communications and Corporate Events to unify the Astellas voice across all internal and external stakeholders.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS. Visit our Facebook page at www.facebook.com/AstellasUS.
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.